Article Details
Retrieved on: 2021-05-21 15:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Protein degradation has caught the attention of Eli Lilly, Roche and other Big Pharmas; led to public offerings of companies like Kymera Therapeutics, ...
Article found on: www.fiercebiotech.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here